Air at 18,000 feet is still 21% oxygen. It is the same air, in the same proportion, as at a beach. What has changed is the pressure pushing it into your blood: a partial pressure of oxygen reported at about 82.67 mmHg on the Siachen Glacier, against roughly 150 mmHg at sea level.
That number — not the thin air of common description, but the pressure gradient behind it — is the whole of high-altitude medicine. And on 12 October 2026 India committed to studying it where it happens.
What was announced
Union Minister for Health and Family Welfare Shri Jagat Prakash Nadda performed the Bhumi Pujan and laid the foundation stone of the ICMR Centre for High Altitude Medicine and Public Health Research at Keylong, in the Lahaul and Spiti district of Himachal Pradesh, at an altitude of about 3,080 metres.
The Centre is a collaboration between the Indian Council of Medical Research, the Armed Forces Medical Services (AFMS) and AIIMS Bilaspur, with the Government of Himachal Pradesh and other national research institutions. Union Minister of State Shri Sanjay Seth noted that the ICMR–Armed Forces collaboration is intended to develop effective medical solutions for extreme-altitude conditions. Shri Jai Ram Thakur and the local Member of Parliament Ms Kangana Ranaut also spoke.
Its declared scope is to study the health implications of low oxygen levels, extreme cold, changing climatic conditions and the distinctive lifestyles of tribal communities — with joint research focused on soldiers and border communities — and to explore drone-enabled medicine delivery, digital health and artificial intelligence to improve healthcare access in remote areas. The stated purpose is to build India's own scientific evidence on Himalayan health.
The physiology, stated correctly
Three illnesses form the altitude syndrome, and they are a standard examination set.
Acute Mountain Sickness (AMS) is the common, usually self-limiting form — headache, nausea, fatigue, poor sleep. Unacclimatised people are at substantial risk above about 2,500 m, and AMS can appear as low as 2,000 m.
High Altitude Cerebral Edema (HACE) presents with AMS-like symptoms that progress to ataxia, confusion and altered mental status. The unsteady gait is the clinical warning sign, and it is why a soldier who cannot walk a straight line at altitude is evacuated rather than rested.
High Altitude Pulmonary Edema (HAPE) is fluid accumulation in the lungs, and it is the commonest cause of death among altitude illnesses. Its mechanism is worth understanding: low oxygen triggers hypoxic pulmonary vasoconstriction, which is normally a useful reflex diverting blood to better-ventilated lung. At altitude the whole lung is hypoxic, the constriction is widespread and uneven, and pressure rises in the capillary beds downstream of the less-constricted vessels until fluid leaks into the alveoli. The patient then cannot oxygenate, which worsens the hypoxia that caused it.
Acclimatisation is the body's partial answer: immediate hyperventilation, a rightward shift in oxygen release to the tissues, and over days to weeks increased erythropoiesis raising red cell mass. Staged ascent and acclimatisation schedules are the standard military protection, and they work.
But the single most important caveat in this entire field is that acclimatisation is incomplete. It reduces risk; it does not abolish it. HAPE occurs in acclimatised people. No schedule makes a soldier physiologically a highlander.
Why this is an operational subject, not a welfare one
Here is the fact that should change how a candidate thinks about altitude.
In reviews of high-altitude warfare in the Kashmir sector, at elevations between about 5,185 and 5,490 metres, it has been reported that both sides acknowledged roughly 80% of casualties were caused by the harsh environmental conditions rather than by enemy action. Indian Army experience from the 1960s recorded HAPE incidence as high as 15.5% among fresh inductees moved rapidly to between 3,355 and 5,490 m, and HAPE mortality has been reported as high as 44% in situations where descent was impossible and supplemental oxygen unavailable — a combination that is unexceptional in combat. These figures come from published medical reviews rather than from primary service records, and should be cited as reported.
Read them together and the conclusion is unavoidable. At extreme altitude, the mountain is the principal threat. An army that acclimatises faster, detects HAPE earlier and evacuates sooner holds more fighting strength on the same ground than one with better weapons and worse medicine. High-altitude medicine is therefore a combat multiplier, in the same category as the cold-weather clothing, the specialised rations and the high-altitude parachute systems qualified for drops at 16,000 feet. The equipment lets you operate there. The medicine decides how many of you are still operating next week.
This is also why the subject recurs in every account of mountain training. A formation moving to the Himalaya from the plains is physiologically a different instrument for its first several weeks, which is precisely the problem that joint mountain exercises are designed around — the issue running through a desert army training at Chaubatia.
Why the research has to be done at Keylong
A reasonable question is why a research centre needs to sit at 3,080 metres when hypobaric chambers exist.
Chambers reproduce low pressure. They do not reproduce the thing soldiers and residents actually live in: low pressure plus extreme cold, very low humidity, high ultraviolet exposure, disrupted sleep, physical exertion, restricted diet and months of continuous exposure. Acclimatisation and its failures are products of that whole environment, and a few hours in a chamber in Delhi cannot generate them.
Keylong also offers something a laboratory cannot: two populations in one district.
The first is acutely exposed — personnel and visitors arriving from low altitude, in whom AMS, HACE and HAPE occur on a predictable timetable. The second is lifelong resident — Himalayan communities whose physiology has adapted over generations. High-altitude populations elsewhere in the world are known to carry genuine genetic and physiological adaptations, and comparing a maladapted newcomer with a native resident is the natural experiment that tells you what adaptation actually consists of.
Having both arms of that comparison in the same valley, with a hospital network and AIIMS Bilaspur studying patients who travel into the region, is a strong research design. It is also the reason the Centre is framed as public health research and not only military physiology: the same oxygen cascade governs a soldier at a forward post and a pregnant woman in Lahaul, and until now India has largely imported the evidence for both.
The existing Indian base for this work sits with DIPAS, the Defence Institute of Physiology and Allied Sciences under DRDO, which runs a High Altitude Physiology Group and has published on acclimatisation strategies — including whether intermittent hypoxia exposure at low altitude can reduce AMS during subsequent ascent. An ICMR civilian centre collaborating with AFMS extends that work from a defence problem into a population-health one.
The drone detail, which is not decoration
The mention of drone-enabled medicine delivery reads like a technology flourish. At altitude it is a clinical intervention.
The definitive treatment for HAPE and HACE is descent, supported by oxygen and specific drugs. In Lahaul and comparable terrain, descent means a single road that may be closed by snow for months, with evacuation measured in many hours. Where the clock is the main determinant of survival, the time to deliver oxygen or a drug to a patient who cannot yet be moved is the variable that matters most.
A delivery that takes forty minutes instead of fourteen hours does not merely improve convenience; it changes the clinical arithmetic of a condition with reported mortality up to 44% when oxygen is unavailable. Combined with digital health and AI-assisted triage at remote posts — deciding which patient must come down now — this is the part of the announcement with the most immediate plausible effect, and it is of a piece with the broader build-out of tiered capacity described in 631 critical care blocks.
What has actually happened
A foundation stone has been laid. No research has been conducted, no cohort recruited and no finding published. The Centre is a commitment, and the timetable will be what construction in Lahaul allows — which, at 3,080 metres with a winter road closure, is not quick.
What has changed is institutional. India has decided to generate its own evidence on a physiology that governs the security of its northern borders and the health of the people who live along them, and to do it jointly between a civilian research council and the military medical service. For a candidate preparing to serve at these altitudes, the physiology above is not examination content alone. It is the reason staged ascent is not optional and the reason an unsteady gait at 4,000 metres is an emergency.
🔑 Revision block
- What: Union Health Minister J.P. Nadda laid the foundation stone of the ICMR Centre for High Altitude Medicine and Public Health Research at Keylong, Lahaul and Spiti, Himachal Pradesh, on 12 October 2026; altitude about 3,080 m.
- Partners: ICMR, Armed Forces Medical Services (AFMS), AIIMS Bilaspur, the Government of Himachal Pradesh; MoS Sanjay Seth on developing solutions for extreme-altitude conditions.
- Scope: low oxygen, extreme cold, changing climate, tribal lifestyles; joint research on soldiers and border communities; drone-enabled medicine delivery, digital health and AI for remote access.
- The core concept: air remains about 21% oxygen at all altitudes. Barometric pressure falls, so the partial pressure of oxygen falls — hypobaric hypoxia. Siachen at 18,000 ft reports a PO₂ of about 82.67 mmHg against roughly 150 mmHg at sea level.
- The three illnesses: AMS (headache, nausea, fatigue; risk above about 2,500 m, possible from 2,000 m); HACE (AMS plus ataxia, confusion, altered mental status); HAPE (pulmonary fluid; the commonest cause of death at altitude).
- HAPE mechanism: hypoxia → widespread, uneven hypoxic pulmonary vasoconstriction → raised capillary pressure → fluid into alveoli → worsening hypoxia.
- Acclimatisation: hyperventilation, shifted oxygen release, and erythropoiesis over days to weeks — but acclimatisation is incomplete and HAPE occurs in the acclimatised.
- Definitive treatment: descent, with oxygen and drugs as support.
- Military significance (as reported in medical reviews): in Kashmir-sector fighting at 5,185–5,490 m, about 80% of casualties were attributed to environmental conditions; 1960s Indian Army HAPE incidence up to 15.5% among fresh inductees moved rapidly to 3,355–5,490 m; HAPE mortality up to 44% without descent or oxygen.
- Existing institution: DIPAS (Defence Institute of Physiology and Allied Sciences, DRDO) and its High Altitude Physiology Group.
- Exam hook: at extreme altitude the environment causes more casualties than the enemy, which makes high-altitude medicine a combat multiplier rather than a welfare measure.
🎯 Practice MCQs
Q1. At high altitude, hypoxia occurs because: (a) The proportion of oxygen in air falls below 21% (b) Barometric pressure falls, reducing the partial pressure of oxygen (c) Carbon dioxide displaces oxygen in the atmosphere (d) Cold air carries less oxygen by volume
→ (b) The composition of air is essentially unchanged with altitude; it is the pressure gradient driving oxygen into the blood that falls. This is hypobaric hypoxia.
Q2. Which high altitude illness is the commonest cause of death? (a) Acute Mountain Sickness (b) High Altitude Cerebral Edema (c) Frostbite (d) High Altitude Pulmonary Edema
→ (d) HAPE is the leading killer among altitude illnesses, and its definitive treatment is descent supported by oxygen.
Q3. The clinical sign that distinguishes HACE from simple AMS is: (a) Ataxia and altered mental status (b) Headache on waking (c) Loss of appetite (d) Shortness of breath on exertion
→ (a) An unsteady gait at altitude is a warning that mandates evacuation rather than rest.
Q4. The mechanism of HAPE involves: (a) Bacterial infection of the alveoli (b) Rupture of the pleural membrane (c) Uneven hypoxic pulmonary vasoconstriction raising capillary pressure (d) Reduced haemoglobin production
→ (c) A reflex that is useful in localised lung hypoxia becomes harmful when the whole lung is hypoxic.
Q5. Unacclimatised individuals face substantial risk of acute altitude illness above approximately: (a) 1,000 m (b) 2,500 m (c) 5,000 m (d) 8,000 m
→ (b) AMS can occur from about 2,000 m, with risk rising substantially above 2,500 m.
Q6. Which statement about acclimatisation is correct? (a) It reduces but does not eliminate the risk of HAPE (b) It makes a visitor physiologically identical to a native highlander (c) It is complete within twenty-four hours (d) It removes the need for staged ascent
→ (a) Acclimatisation is incomplete, which is the single most important caveat in high altitude medicine.
Q7. The ICMR Centre for High Altitude Medicine is being established at: (a) Leh, Ladakh (b) Tawang, Arunachal Pradesh (c) Joshimath, Uttarakhand (d) Keylong, Himachal Pradesh
→ (d) In Lahaul and Spiti district, at an altitude of about 3,080 metres, with AFMS and AIIMS Bilaspur as partners.
Q8. DIPAS, which has long studied high altitude physiology in India, functions under: (a) ICMR (b) The Ministry of Health and Family Welfare (c) DRDO (d) The Department of Biotechnology
→ (c) The Defence Institute of Physiology and Allied Sciences is a DRDO laboratory, and runs a High Altitude Physiology Group.
Q9. Why does drone-enabled delivery matter clinically at high altitude? (a) Because the definitive treatment depends on time, and road evacuation may take many hours (b) Because drones can carry patients to lower altitude (c) Because drugs degrade in cold storage (d) Because diagnosis requires laboratory equipment unavailable locally
→ (a) Where survival turns on how quickly oxygen or a drug reaches a patient who cannot yet be moved, delivery time is the decisive variable.
Q10. The strongest research justification for siting the Centre at altitude rather than using hypobaric chambers is that: (a) Chambers cannot reduce pressure sufficiently (b) Chambers cannot reproduce cold, dryness, exertion and prolonged exposure together, and offer no resident population to compare (c) Research at altitude is cheaper (d) Altitude illness cannot be studied experimentally
→ (b) Keylong offers acutely exposed visitors and lifelong residents in the same district — the two arms of a natural experiment in adaptation.
📋 How this gets asked (PYQ pattern)
High altitude physiology is one of the most reliably examined general-science topics in NDA papers, because it is simultaneously biology, geography and defence.
The first and highest-yield hook is the composition fallacy. Papers repeatedly offer the statement that the percentage of oxygen in air decreases with altitude. It does not. Barometric pressure decreases, and therefore so does partial pressure. If you learn one thing from this topic, learn this, because it also underlies questions on aviation, pressurisation and oxygen masks.
The second is the three illnesses and their order of severity: AMS as the common form, HACE and HAPE as the life-threatening progressions, with HAPE the commonest killer. Expect a question asking which is most fatal, and another asking which presents with ataxia.
The third is the treatment. Descent is definitive. Oxygen, drugs and portable hyperbaric bags are supportive. An option naming rest at the same altitude as the correct management of HACE is a standard distractor and is dangerously wrong in real life as well as in the paper.
The fourth is institutional: DIPAS under DRDO for defence physiology, ICMR for medical research, AFMS as the military medical service. Questions on Indian scientific institutions test the parent organisation above all else.
For an interview, the argument worth carrying is the operational one. Say that in high-altitude conflict the environment has historically caused the great majority of casualties; that acclimatisation reduces but never eliminates risk; and that medical capability at altitude therefore converts directly into available combat strength. That reframes a health topic as a military one, which is exactly the judgement an officer is being assessed for.
Preparing for NDA? On any physiology question, find the mechanism rather than the symptom list — pressure, not percentage; descent, not rest. Build the base with our NDA study material, follow the daily NDA current affairs, and prepare with our faculty in the upcoming Cavalier courses in Delhi.
✍️ Written by Col D.N. Sharma — Faculty, Defence Studies, at The Cavalier. Reviewed by the Cavalier Faculty Desk.